Clinical trial
PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With…
NCT00340704 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00340704 |
|---|---|
| Title | PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder |
| Official title | An Uncontrolled, Open-label, Titration, Long-term Safety (up to 12 Months) and Efficacy Study of Tamsulosin Hydrochloride in Children With Neuropathic Bladder, With a Randomized Pharmacokinetic Sub-study Investigating Low, Medium and High Dose Ranges. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder, Neurogenic |
| Intervention type | Drug |
| Interventions | tamsulosin hydrochloride |
| Enrollment | 143 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jun 21, 2006 |
| Last update posted | Feb 17, 2016 |
| Countries | Belgium, Brazil, Canada, Germany, India, Italy, Mexico, Philippines, Russia, South Africa, South Korea, Spain and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: